Ropes & Gray advised GI Partners, a leading private investment firm, in completing its acquisition of the contract development and manufacturing organization (CDMO) and Cell Solutions businesses from Charles River Laboratories International, forming Rose BioSolutions. The completed transaction was announced on May 7. Financial terms were not disclosed.
Rose BioSolutions is a leading provider of development and advanced manufacturing capabilities across the cell and gene therapy space. As a full-service CDMO, Rose Bio offers manufacturing across the full suite of plasmid DNA, viral vector, and cell therapies, as well as cell supply operations.
The team was led by private equity partners Eric Issadore and Elizabeth Gallucci, employment partner Jen Cormier, IP transactions partner Emily Karlberg, health care partner Christina Bergeron, private equity partner Libby Todd, tax partners Benjamin Rogers and Andrew Howard, data, privacy & cybersecurity partner Fran Faircloth, life sciences regulatory & compliance partners Josh Oyster and Lincoln Tsang, and real estate partner Peter Alpert.
Attorneys
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.